mRNA/SOL
Recent discussions on mRNA technology have been fueled by announcements from Oracle CEO Larry Ellison about the potential of AI in designing personalized mRNA vaccines for cancer treatment, sparking both interest and controversy on X. Oracle CEO Larry Ellison discussed at the White House how AI could soon design personalized mRNA vaccines for individuals to combat cancer, highlighting the promise of AI in healthcare. This announcement has led to a mix of reactions on X, with some users expressing skepticism or outright opposition to mRNA vaccines due to past experiences with COVID-19 mRNA vaccines, while others see potential in the technology for personalized medicine. The debate on X reflects broader concerns about the safety, efficacy, and ethical implications of mRNA technology, especially in light of its rapid development and application during the COVID-19 pandemic.
Score | 31 |
|---|---|
24h Vol | $160.6K |
Liquidity | $2.9K |
Holders | 101 |
Audits | |
Age | 13 hours |
FDV | $3.2K |
Market Cap | $3.2K |
| Addresses | |
|---|---|
| Pool | |
| mRNA | |
| SOL |  |
| Developer |
mRNA to SOL Converter
Score | 31 |
|---|---|
24h Vol | $160.6K |
Liquidity | $2.9K |
Holders | 101 |
Audits | |
Age | 13 hours |
FDV | $3.2K |
Market Cap | $3.2K |
About Moderna Inc (mRNA)
Recent discussions on mRNA technology have been fueled by announcements from Oracle CEO Larry Ellison about the potential of AI in designing personalized mRNA vaccines for cancer treatment, sparking both interest and controversy on X. Oracle CEO Larry Ellison discussed at the White House how AI could soon design personalized mRNA vaccines for individuals to combat cancer, highlighting the promise of AI in healthcare. This announcement has led to a mix of reactions on X, with some users expressing skepticism or outright opposition to mRNA vaccines due to past experiences with COVID-19 mRNA vaccines, while others see potential in the technology for personalized medicine. The debate on X reflects broader concerns about the safety, efficacy, and ethical implications of mRNA technology, especially in light of its rapid development and application during the COVID-19 pandemic.
Update Token InfoOther Pools Trading Moderna Inc (mRNA)
mRNA/SOL Price Stats
The current price of mRNA (mRNA/SOL) on PumpSwap is $0.000003181, the price is up -89.34% in the last 24 hours. Its 24-hour trading volume is reported to be at $160.55K with a total of 5,001 transactions. mRNA/SOL contract address is 8PuiDczBmQuTHtwK4YjtRsViQ74hE2jKZY4ib7wrfxN2, with a Fully Diluted Valuation (FDV) of $3,180.77 and a liquidity pool of $2,902.07.
